FOXP2 and the molecular biology of language: New evidence. II. Molecular aspects and implications for the ontogenesis and phylogeny of language;FOXP2 y la biología molecular del lenguaje: Nuevas evidencias. II. Aspectos moleculares e implicaciones para la ontogenia y la filogenia del lenguaje

Revista de Neurologia

Volumn 46, Issue 6, 2008, Pages 351-359

  Benitez Burraco A ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Basal ganglia; Cortex; FOXP2; Language; Molecular biology; Ontogenesis; Phylogeny

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG;

GENE FUNCTION; GENE IDENTIFICATION; GENE STRUCTURE; GENETIC VARIABILITY; LANGUAGE DEVELOPMENT; MOLECULAR PHYLOGENY; ONTOGENY; PROTEIN DNA INTERACTION; PROTEIN MOTIF; PROTEIN VARIANT; REVIEW; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

EID: 41849097045     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4606.2008124     Document Type: Review

References (74)

1. Benítez-Burraco A. FOXP2: del trastorno específico a la biología molecular del lenguaje. I. Aspectos etiológicos, neuroanatómicos, neurofisiológicos y moleculares. Rev Neurol 2005; 40: 671-82.
2. Benítez-Burraco A. FOXP2: del trastorno específico a la biología molecular del lenguaje. II. Implicaciones para la ontogenia y la filogenia del lenguaje. Rev Neurol 2005; 41: 37-44.
3. Benítez-Burraco A. FOXP2 y la biología molecular del lenguaje: nuevas evidencias. I. Aspectos fenotípicos y modelos animales. Rev Neurol 2008; 46: 289-98.
4. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A novel forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001; 413: 519-23.
5. Haesler S, Wada K, Nshdejan A, Morrisey EE, Lints T, Jarvis ED, et al. FoxP2 expression in avian vocal learners and non-learners. J Neurosci 2004; 24: 3164-75.
6. Teramitsu I, Kudo LC, London SE, Geschwind, DH, White SA. Human brain predicts functional interaction. J. Neurosci 2004; 24: 3152-63.
7. Teramitsu I, White SA. FoxP2 regulation during undirected singing in adult songbirds. J Neurosci 2006; 26: 7390-4.
8. Reiner A, Medina L, Veenman CL. Structural and functional evolution of the basal ganglia in vertebrates. Brain Res Brain Res Rev 1998; 28: 235-85.
9. Ding L, Perkel DJ. Long-term potentiation in an avian basal ganglia nucleus essential for vocal learning. J Neurosci 2004; 24: 488-94.
10. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, Paabo S, et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006; 14: 159-66.
11. Li S, Weidenfeld J, Morrisey EE. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated b, heterotypic and homotypic protein interactions. Mol Cell Biol 2004; 24: 809-22.
12. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005; 102: 5138-43.
13. Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, et al. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet 2007; 81: 1144-57.
14. Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, et al. High-Throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet 2007; 81: 1232-50.
15. Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, et al. Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet 2006; 15: 3154-67.
16. Overdier DG, Porcella A, Costa RH. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol 1994; 14: 2755-66.
17. Bruce HA, Margolis RL. FOXP2: novel exons, splice variants, and CAG repeat length stability. Hum Genet 2002; 111: 136-44.
18. Gusella JF, MacDonald ME. Huntington's disease: seeing the pathogenic process through a genetic lens. Trends Biochem Sci 2006; 31: 533-40.
19. Blennow K, De Leon M, Zetterberg H. Alzheimer's disease. Lancet 2006; 368: 387-403.
20. Lundvig D, Lindersson E, Henning Jensen P. Pathogenic effects of α-synuclein aggregation. Brain Res Mol Brain Res 2005; 134: 3-17.
21. Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist 2003; 9: 311-7.
22. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000; 10: 524-30.
23. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic-Plese S, et al. Aggresomes protect cells b, enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 2003; 12: 749-57.
24. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import b, protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 2001; 21: 3534-46.
25. Berry FB, Saleem RA, Walter MA. FOXC1 transcriptional regulation is mediated b, N- and C-terminal activation domains and contains a phosphorylated transcriptional inhibitory domain. J Biol Chem 2002; 277: 10292-7.
26. Mizutani A, Matsuzaki A, Momoi MY, Fujita E, Tanabe Y, Momoi T. Intracellular distribution of a speech/language disorder associated FOXP2 mutant. Biochem Biophys Res Commun 2007; 353: 869-74.
27. Van der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004; 380: 297-309.
28. Banerjee-Basu S, Baxevanis AD. Structural analysis of disease-causing mutations in the P-subfamily of forkhead transcription factors. Proteins 2004; 54: 639-47.
29. Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3/fork head DNA recognition motif resembles histone H5. Nature 1993; 364: 412-20.
30. Wang B, Lin D, Li C, Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 2003; 278: 24259-68.
31. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001; 276: 37672-9.
32. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445: 936-40.
33. Kiecker C, Lumsden A. Compartments and their boundaries in vertebrate brain development. Nat Rev Neurosci 2005; 6: 553-64.
34. Puelles L, Kuwana E, Puelles E, Bulfone A, Shimamura K, Keleher J, et al. Pallial and subpallial derivatives in the embryonic chick and mouse telencephalon, traced b, the expression of the genes Dlx-2, Emx-1, Nkx-2.1, Pax-6, and Tbr-1. J Comp Neurol 2000; 424: 409-38.
35. Scharff C, Haesler S. An evolutionary perspective on FoxP2: strictly for the birds? Curr Opin Neurobiol 2005; 15: 694-703.
36. Dahmane N, Ruiz-Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999; 126: 3089-100.
37. Shu W, Yang H, Zhang L, Lu MM, Morrisey EE. Characterization of a new subfamily of wingedhelix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J Biol Chem 2001; 276: 27488-97.
38. Anderson SA, Qiu M, Bulfone A, Eisenstat DD, Meneses J, Pedersen, et al. Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons. Neuron 1997; 19: 27-37.
39. Casarosa S, Fode C, Guillemot F. Mash1 regulates neurogenesis in the ventral telencephalon. Development 1999; 126: 525-34.
40. Corbin JG, Gaiano N, Machold RP, Langston A, Fishell G. The Gsh2 homeodomain gene controls multiple aspects of telencephalic development. Development 2000; 127: 5007-20.
41. Wang HF, Liu FC. Developmental restriction of the LIM homeodomain transcription factor Isl-1 expression to cholinergic neurons in the striatum. Neuroscience 2001; 103: 999-1016.
42. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994; 79: 901-12.
43. Rudolph D, Tafuri A, Gass P, Hammerling GJ, Arnold B, Schutz G. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc Natl Acad Sci U S A 1998; 95: 4481-6.
44. Lonze BE, Riccio A, Cohen S, Ginty DD. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 2002; 34: 371-85.
45. Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, Vronskaya S, et al. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002; 34: 447-62.
46. Breslin MB, Zhu M, Lan MS. NeuroD1/E47 regulates the E-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system. J Biol Chem 2003; 278: 38991-7.
47. Yoon JB, Li G, Roeder RG. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol Cell Biol 1994; 14: 1776-85.
48. Bentley GE. Melatonin receptor density in area X of European starlings is correlated with reproductive state and is unaffected b, plasma melatonin concentration. Gen Comp Endocrinol 2003; 134: 187-92.
49. Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 2003; 460: 266-79.
50. Alexander GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
51. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000; 31: 236-50.
52. Watkins KE, Vargha-Khadem F, Ashburner J, Passingham RE, Connelly A, Friston KJ, et al. MRI analysis of an inherited speech and language disorder: structural brain abnormalities. Brain 2002; 125: 465-78.
53. Belton E, Salmond CH, Watkins KE, Vargha-Khadem F, Gadian DG. Bilateral brain abnormalities associated with dominantly inherited verbal and orofacial dyspraxia. Hum Brain Mapp 2003; 18: 194-200.
54. Liégeois F, Baldeweg T, Connelly A, Gadian DG, Mishkin M, Vargha-Khadem F. Language fMRI abnormalities associated with FOXP2 gene mutation. Nat Neurosci 2003; 6: 1230-7.
55. Vargha-Khadem F, Gadian DG, Copp A, Mishkin M. FOXP2 and the neuroanatomy of speech and language. Nat Rev Neurosci 2005; 6: 131-8.
56. Lieberman P. On the nature and evolution of the neural bases of human language. Am J Phys Anthropol 2002; 45: 36-62.
57. Martin RC. Language processing: functional organization and neuroanatomical basis. Annu Rev Psychol 2003; 54: 55-89.
58. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of sterotaxic surgery in Parkinson's disease. Brain 1994; 117: 877-97.
59. Monchi O, Petrides P, Petre V, Worsley K, Dagher A. Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified b, event related functional magnetic resonance imaging. J Neurosci 2001; 21: 7733-41.
60. Graybiel AM. Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 1995; 5: 733-41.
61. Desmond JE, Gabrieli JD, Wagner AD, Ginier BL, Glover GH. Lobular patterns of cerebellar activation in verbal working memory and finger tapping tasks as revealed b, functional MRI. J Neurosci 2006; 17: 9675-85.
62. Desmond JE, Fiez JA. Neuroimaging studies of the cerebellum: language, learning and memory. Trends Cogn Sci 1998; 2: 355-62.
63. Dronkers NF, Shapiro JK, Redfern B, Knight RT. The role of Broca's area in Broca's aphasia. J Clin Exp Neuropsychol 1992; 14: 198.
64. Kimura D. Neuromotor mechanisms in human communication. New York: Oxford University Press; 1993.
65. Blumstein SE. The neurobiology of language. In Miller J, Elmas PD, eds. Speech, language and communication. San Diego: Academic Press; 1995. p. 339-70.
66. Chenery HJ, Copland DA, Murdoch BE. Complex language functions and subcortical mechanisms: evidence from Huntington's disease and patients with non-thalamic subcortical lesions. Int J Lang Commun Disord 2002; 37: 459-74.
67. Teichmann M, Dupoux E, Kouider S, Brugieres P, Boisse MF, Baudic S, et al. The role of the striatum in rule application: the model of Huntington's disease at early stage. Brain 2005; 128: 1155-67.
68. Grossman MG, Carvell S, Gollomp S, Stern MB, Vernon G, Hurtig HI. Sentence comprehension and praxis deficits in Parkinson's disease. Neurology 1991; 41: 1620-8.
69. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-77.
70. Baddeley A. Working memory. Science 1992; 255: 556-9.
71. Ullman MT. The declarative/procedural model of lexicon and grammar. J Psycholinguist Res 2001; 30: 37-69.
72. Pinker S. Rules of language. Science 1991; 253: 530-5.
73. Longworth CE, Keenan SE, Barker RA, Marslen-Wilson WD, Tyler LK. The basal ganglia and rule-governed language use: evidence from vascular and degenerative conditions. Brain 2005; 128: 584-96.
74. Christoff K, Prabhakaran V, Dorfman J, Zhao Z, Kroger JK, Holyoak KJ, et al. Rostrolateral prefrontal cortex involvement in relational integration during reasoning. Neuroimage 2001; 14: 1136-49.